Nifang Niu

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer”.

CDC25B partners with PP2A to induce AMPK activation and tumor suppression in triple negative breast cancer

NAR Cancer(2020)10.1093/narcan/zcaa039

N/A

0DataRank · unranked

27 citations

Reynold C. Ly, Nifang Niu, Krishna R. Kalari, Erin E. Carlson, Liewei Wang +1 more

Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group

Genetics in Medicine(2023)10.1016/j.gim.2023.101036

N/A

0DataRank · unranked

70 citations

Marcie Steeves, Pınar Bayrak‐Toydemir, Katherine A. Benson, Bradley P. Coe, Laura K. Conlin +42 more

Data from Genetic Variation Predicting Cisplatin Cytotoxicity Associated with Overall Survival in Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2023)10.1158/1078-0432.c.6520376.v1

N/A

0DataRank · unranked

0 citations

Ann M. Moyer, Brooke L. Fridley, Daniel J. Schaid, Nifang Niu, Anthony Batzler +8 more